Cargando…
Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3
We have obtained the 1.7 Å crystal structure of FIV protease (PR) in which 12 critical residues around the active site have been substituted with the structurally equivalent residues of HIV PR (12X FIV PR). The chimeric PR was crystallized in complex with the broad-based inhibitor TL-3, which inhibi...
Autores principales: | Heaslet, Holly, Lin, Ying-Chuan, Tam, Karen, Torbett, Bruce E, Elder, John H, Stout, C David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781954/ https://www.ncbi.nlm.nih.gov/pubmed/17212810 http://dx.doi.org/10.1186/1742-4690-4-1 |
Ejemplares similares
-
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3
por: de Rozières, Sohela, et al.
Publicado: (2004) -
Applications of the FIV Model to Study HIV Pathogenesis
por: Miller, Craig, et al.
Publicado: (2018) -
FIV as a Model for HIV: An Overview
por: Sparger, Ellen E.
Publicado: (2006) -
Evaluation of a Point-of-Care Feline Immunodeficiency Virus (FIV) Test Kit (RapidSTATUS™ FIV) to Determine the FIV Status of FIV-Vaccinated and FIV-Unvaccinated Pet Cats in Australia
por: Cheang, Ashley, et al.
Publicado: (2022) -
Pathogenesis of oral FIV infection
por: Miller, Craig, et al.
Publicado: (2017)